ID   WASL_RAT                Reviewed;         501 AA.
AC   O08816;
DT   27-APR-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-JAN-1998, sequence version 2.
DT   27-MAR-2024, entry version 203.
DE   RecName: Full=Actin nucleation-promoting factor WASL {ECO:0000305};
DE   AltName: Full=Neural Wiskott-Aldrich syndrome protein;
DE            Short=N-WASP;
GN   Name=Wasl;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=9322739; DOI=10.1016/s0378-1119(97)00184-4;
RA   Fukuoka M., Miki H., Takenawa T.;
RT   "Identification of N-WASP homologs in human and rat brain.";
RL   Gene 196:43-48(1997).
RN   [2]
RP   INTERACTION WITH PTK2/FAK1, SUBCELLULAR LOCATION, AND PHOSPHORYLATION AT
RP   TYR-253.
RX   PubMed=14676198; DOI=10.1074/jbc.m310739200;
RA   Wu X., Suetsugu S., Cooper L.A., Takenawa T., Guan J.L.;
RT   "Focal adhesion kinase regulation of N-WASP subcellular localization and
RT   function.";
RL   J. Biol. Chem. 279:9565-9576(2004).
RN   [3]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-253, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
RN   [4]
RP   STRUCTURE BY NMR OF 37-485.
RX   PubMed=12437929; DOI=10.1016/s0092-8674(02)01076-0;
RA   Volkman B.F., Prehoda K.E., Scott J.A., Peterson F.C., Lim W.A.;
RT   "Structure of the N-WASP EVH1 domain-WIP complex: insight into the
RT   molecular basis of Wiskott-Aldrich Syndrome.";
RL   Cell 111:565-576(2002).
CC   -!- FUNCTION: Regulates actin polymerization by stimulating the actin-
CC       nucleating activity of the Arp2/3 complex. Involved in various
CC       processes, such as mitosis and cytokinesis, via its role in the
CC       regulation of actin polymerization. Together with CDC42, involved in
CC       the extension and maintenance of the formation of thin, actin-rich
CC       surface projections called filopodia. In addition to its role in the
CC       cytoplasm, also plays a role in the nucleus by regulating gene
CC       transcription, probably by promoting nuclear actin polymerization (By
CC       similarity). Binds to HSF1/HSTF1 and forms a complex on heat shock
CC       promoter elements (HSE) that negatively regulates HSP90 expression.
CC       Plays a role in dendrite spine morphogenesis (By similarity).
CC       {ECO:0000250|UniProtKB:O00401, ECO:0000250|UniProtKB:Q91YD9}.
CC   -!- SUBUNIT: Binds actin and the Arp2/3 complex. Interacts with CDC42 (By
CC       similarity). Interacts with FCHSD1. Interacts with FCHSD2 (By
CC       similarity). Binds to SH3 domains of GRB2. Interacts with the C-
CC       terminal SH3 domain of DNMBP (By similarity). Interacts with SNX9 (By
CC       similarity). Interacts with the WW domains of PRPF40A/FBP11 (By
CC       similarity). Interacts with PTK2/FAK1 (PubMed:14676198). Interacts with
CC       PACSIN1, PACSIN2 and PACSIN3 (By similarity). Interacts with NOSTRIN.
CC       Binds to TNK2. Interacts with SNX33. Interacts with NONO (via second
CC       RRM domain); the interaction is direct. Component of a multiprotein
CC       complex with NONO and SFPQ; associates with the complex via direct
CC       interaction with NONO (By similarity). {ECO:0000250|UniProtKB:O00401,
CC       ECO:0000250|UniProtKB:Q91YD9, ECO:0000250|UniProtKB:Q95107,
CC       ECO:0000269|PubMed:14676198}.
CC   -!- INTERACTION:
CC       O08816; O08816: Wasl; NbExp=3; IntAct=EBI-6142604, EBI-6142604;
CC       O08816; Q6IN36: Wipf1; NbExp=2; IntAct=EBI-6142604, EBI-6986245;
CC       O08816; P60953: CDC42; Xeno; NbExp=2; IntAct=EBI-6142604, EBI-81752;
CC       O08816; Q60598: Cttn; Xeno; NbExp=2; IntAct=EBI-6142604, EBI-397955;
CC       O08816; P0DJ88: espF(U); Xeno; NbExp=4; IntAct=EBI-6142604, EBI-10039462;
CC       O08816; Q8X482: espF(U); Xeno; NbExp=5; IntAct=EBI-6142604, EBI-22229752;
CC       O08816; Q8IVI9: NOSTRIN; Xeno; NbExp=3; IntAct=EBI-6142604, EBI-1391643;
CC       O08816; P07737: PFN1; Xeno; NbExp=4; IntAct=EBI-6142604, EBI-713780;
CC       O08816; P35080: PFN2; Xeno; NbExp=3; IntAct=EBI-6142604, EBI-473138;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:14676198}. Nucleus {ECO:0000269|PubMed:14676198}.
CC       Cytoplasm {ECO:0000250|UniProtKB:Q91YD9}. Note=Preferentially localized
CC       in the cytoplasm when phosphorylated and in the nucleus when
CC       unphosphorylated (By similarity). Exported from the nucleus by an
CC       nuclear export signal (NES)-dependent mechanism to the cytoplasm (By
CC       similarity). {ECO:0000250|UniProtKB:Q91YD9}.
CC   -!- PTM: Phosphorylation at Ser-239, Tyr-253, Ser-480 and Ser-481 enhances
CC       actin polymerization activity. {ECO:0000250|UniProtKB:O00401}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D88461; BAA21534.1; -; mRNA.
DR   PDB; 1MKE; NMR; -; A=26-147.
DR   PDB; 2IFS; NMR; -; A=26-147.
DR   PDBsum; 1MKE; -.
DR   PDBsum; 2IFS; -.
DR   AlphaFoldDB; O08816; -.
DR   BMRB; O08816; -.
DR   SMR; O08816; -.
DR   DIP; DIP-17016N; -.
DR   ELM; O08816; -.
DR   IntAct; O08816; 19.
DR   MINT; O08816; -.
DR   STRING; 10116.ENSRNOP00000009261; -.
DR   BindingDB; O08816; -.
DR   ChEMBL; CHEMBL3774296; -.
DR   iPTMnet; O08816; -.
DR   PhosphoSitePlus; O08816; -.
DR   jPOST; O08816; -.
DR   PaxDb; 10116-ENSRNOP00000009261; -.
DR   UCSC; RGD:735144; rat.
DR   AGR; RGD:735144; -.
DR   RGD; 735144; Wasl.
DR   eggNOG; KOG3671; Eukaryota.
DR   InParanoid; O08816; -.
DR   PhylomeDB; O08816; -.
DR   EvolutionaryTrace; O08816; -.
DR   PRO; PR:O08816; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0030478; C:actin cap; ISO:RGD.
DR   GO; GO:0031252; C:cell leading edge; IDA:RGD.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IDA:BHF-UCL.
DR   GO; GO:0005829; C:cytosol; ISO:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0000139; C:Golgi membrane; IDA:RGD.
DR   GO; GO:0030027; C:lamellipodium; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0098794; C:postsynapse; IDA:SynGO.
DR   GO; GO:0003779; F:actin binding; IEA:UniProtKB-KW.
DR   GO; GO:0008092; F:cytoskeletal protein binding; IPI:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0030036; P:actin cytoskeleton organization; ISO:RGD.
DR   GO; GO:0030041; P:actin filament polymerization; ISS:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0060997; P:dendritic spine morphogenesis; ISS:UniProtKB.
DR   GO; GO:0010324; P:membrane invagination; IDA:BHF-UCL.
DR   GO; GO:2000402; P:negative regulation of lymphocyte migration; ISO:RGD.
DR   GO; GO:1903526; P:negative regulation of membrane tubulation; ISO:RGD.
DR   GO; GO:0097320; P:plasma membrane tubulation; IDA:BHF-UCL.
DR   GO; GO:0050921; P:positive regulation of chemotaxis; IMP:RGD.
DR   GO; GO:2000370; P:positive regulation of clathrin-dependent endocytosis; IDA:BHF-UCL.
DR   GO; GO:0051491; P:positive regulation of filopodium assembly; IDA:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0099173; P:postsynapse organization; IDA:SynGO.
DR   GO; GO:0098974; P:postsynaptic actin cytoskeleton organization; IDA:SynGO.
DR   GO; GO:0031503; P:protein-containing complex localization; ISO:RGD.
DR   GO; GO:0060491; P:regulation of cell projection assembly; IMP:RGD.
DR   GO; GO:0099175; P:regulation of postsynapse organization; ISO:RGD.
DR   GO; GO:0032880; P:regulation of protein localization; ISO:RGD.
DR   GO; GO:0009617; P:response to bacterium; ISO:RGD.
DR   GO; GO:0051653; P:spindle localization; ISO:RGD.
DR   GO; GO:0006900; P:vesicle budding from membrane; IDA:BHF-UCL.
DR   GO; GO:0016050; P:vesicle organization; IDA:BHF-UCL.
DR   GO; GO:0030050; P:vesicle transport along actin filament; IDA:BHF-UCL.
DR   CDD; cd00132; CRIB; 1.
DR   CDD; cd01205; EVH1_WASP-like; 1.
DR   CDD; cd22075; WH2_hN-WASP_r2_like; 1.
DR   CDD; cd22074; WH2_N-WASP_r1; 1.
DR   Gene3D; 3.90.810.10; CRIB domain; 2.
DR   Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 1.
DR   InterPro; IPR000095; CRIB_dom.
DR   InterPro; IPR036936; CRIB_dom_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR011026; WAS_C.
DR   InterPro; IPR033927; WASPfam_EVH1.
DR   InterPro; IPR000697; WH1/EVH1_dom.
DR   InterPro; IPR003124; WH2_dom.
DR   PANTHER; PTHR11202:SF36; NEURAL WISKOTT-ALDRICH SYNDROME PROTEIN; 1.
DR   PANTHER; PTHR11202; SPROUTY-RELATED, EVH1 DOMAIN-CONTAINING PROTEIN FAMILY MEMBER; 1.
DR   Pfam; PF00786; PBD; 1.
DR   Pfam; PF00568; WH1; 1.
DR   Pfam; PF02205; WH2; 2.
DR   SMART; SM00285; PBD; 1.
DR   SMART; SM00461; WH1; 1.
DR   SMART; SM00246; WH2; 2.
DR   SUPFAM; SSF50729; PH domain-like; 1.
DR   SUPFAM; SSF47912; Wiscott-Aldrich syndrome protein, WASP, C-terminal domain; 2.
DR   PROSITE; PS50108; CRIB; 1.
DR   PROSITE; PS50229; WH1; 1.
DR   PROSITE; PS51082; WH2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Actin-binding; Cell cycle; Cell division;
KW   Cytoplasm; Cytoskeleton; Methylation; Mitosis; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Transcription; Transcription regulation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:O00401"
FT   CHAIN           2..501
FT                   /note="Actin nucleation-promoting factor WASL"
FT                   /id="PRO_0000189002"
FT   DOMAIN          31..138
FT                   /note="WH1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00410"
FT   DOMAIN          200..213
FT                   /note="CRIB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00057"
FT   DOMAIN          401..418
FT                   /note="WH2 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00406"
FT   DOMAIN          429..446
FT                   /note="WH2 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00406"
FT   REGION          135..159
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          180..202
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          263..405
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          442..501
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        271..390
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        442..459
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        482..501
FT                   /note="Acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000250|UniProtKB:O00401"
FT   MOD_RES         239
FT                   /note="Phosphoserine; by TNK2"
FT                   /evidence="ECO:0000250|UniProtKB:O00401"
FT   MOD_RES         253
FT                   /note="Phosphotyrosine; by FAK1 and TNK2"
FT                   /evidence="ECO:0000269|PubMed:14676198,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         304
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:O00401"
FT   MOD_RES         480
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O00401"
FT   MOD_RES         481
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O00401"
FT   TURN            8..11
FT                   /evidence="ECO:0007829|PDB:1MKE"
FT   STRAND          13..16
FT                   /evidence="ECO:0007829|PDB:1MKE"
FT   STRAND          19..21
FT                   /evidence="ECO:0007829|PDB:2IFS"
FT   STRAND          36..49
FT                   /evidence="ECO:0007829|PDB:1MKE"
FT   TURN            50..52
FT                   /evidence="ECO:0007829|PDB:1MKE"
FT   STRAND          53..67
FT                   /evidence="ECO:0007829|PDB:1MKE"
FT   TURN            68..71
FT                   /evidence="ECO:0007829|PDB:1MKE"
FT   STRAND          72..78
FT                   /evidence="ECO:0007829|PDB:1MKE"
FT   STRAND          80..82
FT                   /evidence="ECO:0007829|PDB:1MKE"
FT   STRAND          84..90
FT                   /evidence="ECO:0007829|PDB:1MKE"
FT   STRAND          100..108
FT                   /evidence="ECO:0007829|PDB:1MKE"
FT   STRAND          110..120
FT                   /evidence="ECO:0007829|PDB:1MKE"
FT   HELIX           121..137
FT                   /evidence="ECO:0007829|PDB:1MKE"
SQ   SEQUENCE   501 AA;  54325 MW;  480E21F26F7FC77E CRC64;
     MSSGQQPPRR VTNVGSLLLT PQENESLFSF LGKKCVTMSS AVVQLYAADR NCMWSKKCSG
     VACLVKDNPQ RSYFLRIFDI KDGKLLWEQE LYNNFVYNSP RGYFHTFAGD TCQVALNFAN
     EEEAKKFRKA VTDLLGRRQR KSEKRRDAPN GPNLPMATVD IKNPEITTNR FYSSQVNNIS
     HTKEKKKGKA KKKRLTKADI GTPSNFQHIG HVGWDPNTGF DLNNLDPELK NLFDMCGISE
     AQLKDRETSK VIYDFIEKTG GVEAVKNELR RQAPPPPPPS RGGPPPPPPP PHSSGPPPPP
     ARGRGAPPPP PSRAPTAAPP PPPPSRPGVV VPPPPPNRMY PPPPPALPSS APSGPPPPPP
     LSMAGSTAPP PPPPPPPPPG PPPPPGLPSD GDHQVPASSG NKAALLDQIR EGAQLKKVEQ
     NSRPVSCSGR DALLDQIRQG IQLKSVSDGQ ESTPPTPAPT SGIVGALMEV MQKRSKAIHS
     SDEDEDDDDE EDFQDDDEWE D
//
